Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q99873
UPID:
ANM1_HUMAN
Alternative names:
Histone-arginine N-methyltransferase PRMT1; Interferon receptor 1-bound protein 4
Alternative UPACC:
Q99873; A0A087X1W2; B4E3C3; G5E9B6; H7C2I1; Q15529; Q2VP93; Q6LEU5; Q8WUW5; Q99872; Q99874; Q9NZ04; Q9NZ05; Q9NZ06
Background:
Protein arginine N-methyltransferase 1 (PRMT1), also known as Histone-arginine N-methyltransferase PRMT1 and Interferon receptor 1-bound protein 4, plays a pivotal role in methylating arginyl residues in proteins such as ESR1, histones, and FOXO1. This enzyme is crucial for epigenetic transcriptional activation, influencing estrogen receptor-mediated transactivation, neurite outgrowth, and cellular differentiation processes.
Therapeutic significance:
Understanding the role of Protein arginine N-methyltransferase 1 could open doors to potential therapeutic strategies.